The global implications of the gentamicin histamine contamination- sorting fact from fiction [Letters]

On the 6^th of October 2017 the Therapeutics Goods Administration (TGA) in conjunction with Pfizer Australia released a statement to recall 10 batches of gentamicin Infection BP 80mg in 2ml Steriluer ampoules, due to the finding that these batches may have contained higher than expected amounts of histamine, a residual from the manufacturing process(1)....

https://ift.tt/2AtpC0G